Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carlos Javier Cerveró
Observed names:
C Cerveró,
C. Cervero,
C. Cerveró,
Carlos Cervero,
Carlos Cerveró,
Carlos Cerveró,
Carlos J. Cervero,
Carlos Javier Cervero,
Cerveró, Carlos
show all 9
Institution:
Hospital Virgen de la Luz
Observed institutions:
Universidad de Salamanca,
Universidad de Alcalá,
Hospital Virgen de la Luz,
Hospital Universitario Ramón y Cajal
OpenAlex ID:
A5087231606
Indolent Systemic Mast Cell Disease in Adults: Immunophenotypic Characterization of Bone Marrow Mast Cells and Its Diagnostic Implications
1998
·
Luis Escribano
, Alberto Orfao
, et al.
·
Blood
·
256
Immunophenotypic Characterization of Human Bone Marrow Mast Cells. A Flow Cytometric Study of Normal and Pathological Bone Marrow Samples
1998
·
Luis Escribano
, Alberto Orfao
, et al.
·
Analytical Cellular Pathology
·
83
Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study.
1994
·
J López-Jiménez
, C Cerveró
, et al.
·
PubMed
·
51
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
2022
·
A. Luna
, L. Pérez-Lamas
, et al.
·
Annals of Hematology
·
43
Expression of lymphoid‐associated antigens in mast cells: report of a case of systemic mast cell disease
1995
·
Luis Escribano
, Alberto Orfao
, et al.
·
British Journal of Haematology
·
41
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors
2023
·
Lucía Pérez-Lamas
, Alejandro Luna
, et al.
·
Cancers
·
38
PDF
Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients—diagnostic and clinical implications
1998
·
R Luque
, J A Brieva
, et al.
·
Clinical & Experimental Immunology
·
38
PDF
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group
2021
·
Tomás Palanques-Pastor
, Juan Eduardo Megías-Vericat
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
36
PDF
Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients
2008
·
Sandra Quijano
, Antonio López
, et al.
·
Blood
·
27
Cell‐cycle distribution of different cell compartments in normal versus reactive bone marrow: A frame of reference for the study of dysplastic hematopoiesis
2011
·
Sergio Matarraz
, Carlos Fernandez
, et al.
·
Cytometry Part B Clinical Cytometry
·
26
The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome
2012
·
Sergio Matarraz
, Cristina Teodosio
, et al.
·
PLoS ONE
·
25
PDF
Multivariate time‐dependent comparison of the impact of lenalidomide in lower‐risk myelodysplastic syndromes with chromosome 5q deletion
2014
·
Joaquín Sánchez‐García
, Consuelo del Cañizo
, et al.
·
British Journal of Haematology
·
19
PDF
Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome
2013
·
Judit Sánchez-Castro
, Víctor Marco-Betés
, et al.
·
Leukemia Research
·
18
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: Review of 5,654 patients with an evaluable karyotype
2013
·
Dolors Costa
, Concha Muñoz
, et al.
·
Genes Chromosomes and Cancer
·
16
Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis
2013
·
C Fernandez
, M C Santos-Silva
, et al.
·
Leukemia
·
14
Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis
2013
·
Silvia M. Rojas
, María Díez-Campelo
, et al.
·
Leukemia Research
·
11
Clinical outcomes after CPX ‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
2023
·
Teresa Bernal
, Ainhoa Fernández Moreno
, et al.
·
Cancer Medicine
·
10
PDF
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes
2024
·
Juan Carlos Caballero
, Julio Dávila
, et al.
·
Therapeutic Advances in Hematology
·
8
PDF
Differences in Ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia
2019
·
Juan Eduardo Megias-Vericat
, David Martínez-Cuadrón
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
8
Posttransfusion hepatitis after induction chemotherapy in acute nonlymphoblastic leukemia: implications for long‐term management and outcome
1995
·
J. López‐Jimenez
, J. A. Cancelas
, et al.
·
Transfusion
·
7
Toxicity of Asciminib in Real Clinical Practice; Analysis of Side Effects and Cross-Intolerance with Tyrosine Kinase Inhibitors
2022
·
Lucía Pérez-Lamas
, Alejandro Luna
, et al.
·
Blood
·
6
Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib
2024
·
Lucía Pérez-Lamas
, Adrián Segura Díaz
, et al.
·
Annals of Hematology
·
5
PDF
Asciminib in Real-Life Clinical Practice, Safety and Efficacy Profile in Chronic Myeloid Leukemia Pretreated Patients
2021
·
Lucía Pérez-Lamas
, Alejandro Luna
, et al.
·
Blood
·
4
Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry
2020
·
Pilar Martínez
, Tomás Palanques Pastor
, et al.
·
Blood
·
4
PDF
[Chediak-Higashi-like inclusions in acute myeloblastic leukemia. Ultrastructural study].
1994
·
C Cerveró
, B Heinrichs
, et al.
·
PubMed
·
4
Show more works
View as search
Works count:
43
Citation count:
818
H-index:
14
I10-index:
17
Year
Topic
Type